标题
Oridonin enhances antitumor effects of doxorubicin in human osteosarcoma cells
作者
关键词
-
出版物
Pharmacological Reports
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-08-24
DOI
10.1007/s43440-021-00324-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
- (2019) Anastasiya V. Snezhkina et al. Oxidative Medicine and Cellular Longevity
- Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects
- (2019) Jingjing Li et al. PHARMACOLOGICAL RESEARCH
- Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway
- (2018) Ying Lu et al. Cell Death & Disease
- Oridonin synergizes with Nutlin-3 in osteosarcoma cells by modulating the levels of multiple Bcl-2 family proteins
- (2017) Xiao-Hui Wang et al. TUMOR BIOLOGY
- Escin induces caspase-dependent apoptosis and autophagy through the ROS/p38 MAPK signalling pathway in human osteosarcoma cells in vitro and in vivo
- (2017) Jian Zhu et al. Cell Death & Disease
- Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells
- (2017) Zhuo Yao et al. Cell Death & Disease
- Oridonin inhibits breast cancer growth and metastasis through blocking the Notch signaling
- (2017) Shixin Xia et al. SAUDI PHARMACEUTICAL JOURNAL
- Oridonin induces apoptosis and reverses drug resistance in cisplatin resistant human gastric cancer cells
- (2017) Zhongwei He et al. Oncology Letters
- Mcl-1 regulates reactive oxygen species via NOX4 during chemotherapy-induced senescence
- (2017) Abeba Demelash et al. Oncotarget
- Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells
- (2016) Xinjun Dong et al. ANTI-CANCER DRUGS
- Update on Survival in Osteosarcoma
- (2016) Megan E. Anderson ORTHOPEDIC CLINICS OF NORTH AMERICA
- Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim
- (2014) Hye-Kyung Park et al. BMC CANCER
- The Efficacy of Abraxane on Osteosarcoma Xenografts in Nude Mice and Expression of Secreted Protein, Acidic and Rich in Cysteine
- (2012) Yongkun Yang et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Anti-cancer natural products isolated from chinese medicinal herbs
- (2011) Wen Tan et al. Chinese Medicine
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects
- (2010) Katherine A Janeway et al. LANCET ONCOLOGY
- Doxorubicin pathways
- (2010) Caroline F. Thorn et al. Pharmacogenetics and Genomics
- Mechanisms of drug combinations: interaction and network perspectives
- (2009) Jia Jia et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More